Structure Therapeutics (GPCR) News Today $18.53 -0.63 (-3.29%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$18.93 +0.40 (+2.16%) As of 08/14/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GPCR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Eli Lilly, Superluminal Medicines announce collaborationAugust 14 at 3:39 PM | msn.comCan Structure Therapeutics’ (GPCR) Aggressive Funding Moves Accelerate Its Obesity Drug Ambitions?August 13 at 5:21 AM | finance.yahoo.comFY2025 EPS Estimates for GPCR Lowered by Cantor FitzgeraldAugust 12 at 3:22 AM | marketbeat.comFY2025 EPS Estimates for GPCR Decreased by HC WainwrightAugust 12 at 3:22 AM | marketbeat.comEquities Analysts Set Expectations for GPCR FY2025 EarningsAugust 12 at 3:09 AM | americanbankingnews.comGPCR FY2025 EPS Estimate Cut by Cantor FitzgeraldAugust 12 at 3:09 AM | americanbankingnews.comLeerink Partnrs Has Negative Estimate for GPCR Q3 EarningsAugust 12 at 2:03 AM | americanbankingnews.comStructure Therapeutics To Present Late-Breaking ADA Data on Oral Amylin Agonist ACCG-2671August 11, 2025 | msn.comWilliam Blair Issues Pessimistic Outlook for GPCR EarningsAugust 11, 2025 | americanbankingnews.comLeerink Partnrs Has Negative Forecast for GPCR Q3 EarningsAugust 11, 2025 | marketbeat.comWilliam Blair Has Bearish Forecast for GPCR Q3 EarningsAugust 11, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPSAugust 10, 2025 | marketbeat.comLeerink Partnrs Issues Negative Forecast for GPCR EarningsAugust 9, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Price Target Lowered to $60.00 at HC WainwrightAugust 8, 2025 | marketbeat.comGuggenheim Issues Pessimistic Forecast for Structure Therapeutics (NASDAQ:GPCR) Stock PriceAugust 8, 2025 | marketbeat.comJMP Securities Has Lowered Expectations for Structure Therapeutics (NASDAQ:GPCR) Stock PriceAugust 8, 2025 | marketbeat.comStructure Therapeutics (GPCR) to Release Quarterly Earnings on ThursdayAugust 7, 2025 | marketbeat.comStructure Therapeutics Reports Second Quarter 2025 Financial Results and Recent HighlightsAugust 6, 2025 | globenewswire.comStructure Therapeutics (NASDAQ:GPCR) Trading Down 4.2% - What's Next?August 5, 2025 | marketbeat.comStructure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Shares Sold by TD Asset Management IncAugust 5, 2025 | marketbeat.comFederated Hermes Inc. Sells 875,010 Shares of Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR)August 2, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Lowers Stock Holdings in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR)August 2, 2025 | marketbeat.comStructure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by BrokeragesJuly 28, 2025 | marketbeat.comReadystate Asset Management LP Increases Stock Position in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR)July 22, 2025 | marketbeat.comPrincipal Financial Group Inc. Lowers Holdings in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR)July 13, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading Down 7.3% - Here's WhyJuly 7, 2025 | marketbeat.comStructure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Average Rating of "Buy" from BrokeragesJuly 3, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Shares Down 4% - Here's WhyJune 26, 2025 | marketbeat.comJefferies Reiterates a Buy Rating on Structure Therapeutics (GPCR) With a $79 PTJune 24, 2025 | msn.comStructure Therapeutics (NASDAQ:GPCR) Shares Up 4.7% - Time to Buy?June 23, 2025 | marketbeat.comCantor Fitzgerald Reaffirms "Overweight" Rating for Structure Therapeutics (NASDAQ:GPCR)June 23, 2025 | marketbeat.comJMP Securities Reiterates "Market Outperform" Rating for Structure Therapeutics (NASDAQ:GPCR)June 23, 2025 | marketbeat.comStructure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671June 20, 2025 | globenewswire.comHandelsbanken Fonder AB Buys 215,000 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)June 13, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading Down 4.5% - Time to Sell?June 12, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Shares Up 9.4% - Still a Buy?June 11, 2025 | marketbeat.comEquities Analysts Set Expectations for GPCR FY2026 EarningsJune 11, 2025 | marketbeat.comCantor Fitzgerald Predicts GPCR FY2025 EarningsJune 10, 2025 | marketbeat.comStructure Therapeutics: Why Aleniglipron's Path To Market Remains TreacherousJune 10, 2025 | seekingalpha.comStructure Therapeutics Inc. (NASDAQ:GPCR) Given Average Recommendation of "Buy" by BrokeragesJune 8, 2025 | marketbeat.comBank of America Corp DE Has $1.47 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR)June 5, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New $3.09 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)June 3, 2025 | marketbeat.comBNP Paribas Financial Markets Makes New $304,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)May 29, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 4.6% - Here's WhyMay 28, 2025 | marketbeat.comZimmer Partners LP Sells 154,200 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 23, 2025 | marketbeat.comVestal Point Capital LP Raises Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)May 21, 2025 | marketbeat.comWexford Capital LP Sells 16,351 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 21, 2025 | marketbeat.comTema Etfs LLC Acquires New Shares in Structure Therapeutics Inc. (NASDAQ:GPCR)May 20, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by Point72 Europe London LLPMay 18, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Receives Average Recommendation of "Buy" from AnalystsMay 16, 2025 | marketbeat.com Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address GPCR Media Mentions By Week GPCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GPCR News Sentiment▼-0.410.61▲Average Medical News Sentiment GPCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GPCR Articles This Week▼325▲GPCR Articles Average Week Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACADIA Pharmaceuticals News Arcellx News Akero Therapeutics News Viking Therapeutics News Metsera News SpringWorks Therapeutics News Scholar Rock News MoonLake Immunotherapeutics News Protagonist Therapeutics News Ascentage Pharma Group International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GPCR) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access